WELL Health Technologies Forecast, price target & analysts
WELL Health Technologies Target price 2025 - Analyst rating & recommendation
WELL Health Technologies Classifications & Recommendation:
WELL Health Technologies Price Target
| Target Price | C$7.70 |
| Price | C$3.97 |
| Potential |
93.98%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target WELL Health Technologies 2026 .
The average WELL Health Technologies target price is C$7.70.
This is
93.98%
register free of charge
C$9.45
138.04%
register free of charge
C$5.56
39.92%
register free of charge
|
|
| A rating was issued by 20 analysts: 18 Analysts recommend WELL Health Technologies to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the WELL Health Technologies stock has an average upside potential 2026 of
93.98%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion C$ | 0.92 | 1.43 |
| 18.51% | 55.38% | |
| EBITDA Margin | 4.52% | 14.27% |
| 63.22% | 215.94% | |
| Net Margin | 3.55% | 5.62% |
| 34,296.09% | 58.50% |
16 Analysts have issued a sales forecast WELL Health Technologies 2025 . The average WELL Health Technologies sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an WELL Health Technologies EBITDA forecast 2025. The average WELL Health Technologies EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 WELL Health Technologies Analysts have issued a net profit forecast 2025. The average WELL Health Technologies net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share C$ | 0.13 | 0.32 |
| 146.15% | ||
| P/E | 12.56 |
15 Analysts have issued a WELL Health Technologies forecast for earnings per share. The average WELL Health Technologies EPS is
This results in the following potential growth metrics and future valuations:
WELL Health Technologies...
Current WELL Health Technologies Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| PARADIGM CAPITAL |
Locked
➜
Locked
|
Locked | Dec 12 2025 |
| STIFEL CANADA |
Locked
➜
Locked
|
Locked | Dec 08 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Dec 03 2025 |
| FREEDOM BROKER |
Locked
➜
Locked
|
Locked | Nov 17 2025 |
| CIBC CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| RAYMOND JAMES LTD. |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| VENTUM FINANCIAL CORP. |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
PARADIGM CAPITAL:
Locked
➜
Locked
|
Dec 12 2025 |
|
Locked
STIFEL CANADA:
Locked
➜
Locked
|
Dec 08 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Dec 03 2025 |
|
Locked
FREEDOM BROKER:
Locked
➜
Locked
|
Nov 17 2025 |
|
Locked
CIBC CAPITAL MARKETS:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
VENTUM FINANCIAL CORP.:
Locked
➜
Locked
|
Nov 13 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
